Summary

Investigators from the Efficacy Study of Drug-Eluting and Bare Metal Stents in Bypass Graft Lesions [ISAR-CABG; NCT00611910] report that treatment of saphenous vein graft lesions with drug-eluting stents may decrease the long-term need for repeat target lesion revascularization by approximately 50% compared with bare metal stents, making DES the preferred way to reduce restenosis in bypass grafts.